Credit Suisse’s Medpace MEDP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $13.8M | Sell |
34,062
-336
| -1% | -$118K | 0.01% | 781 |
|
|
2023
Q4 | $10.5M | Buy |
34,398
+487
| +1% | +$131K | 0.01% | 899 |
|
|
2023
Q3 | $8.21M | Buy |
33,911
+804
| +2% | +$206K | 0.01% | 986 |
|
|
2023
Q2 | $7.95M | Buy |
33,107
+3,588
| +12% | +$745K | 0.01% | 1046 |
|
|
2023
Q1 | $5.55M | Buy |
29,519
+1,001
| +4% | +$207K | 0.01% | 1237 |
|
|
2022
Q4 | $6.06M | Buy |
28,518
+1,556
| +6% | +$311K | 0.01% | 1187 |
|
|
2022
Q3 | $4.24M | Sell |
26,962
-1,522
| -5% | -$243K | ﹤0.01% | 1355 |
|
|
2022
Q2 | $4.26M | Sell |
28,484
-8,166
| -22% | -$1.18M | ﹤0.01% | 1394 |
|
|
2022
Q1 | $6M | Buy |
36,650
+481
| +1% | +$79.3K | 0.01% | 1342 |
|
|
2021
Q4 | $7.87M | Sell |
36,169
-2,718
| -7% | -$569K | ﹤0.01% | 1681 |
|
|
2021
Q3 | $7.36M | Sell |
38,887
-1,063
| -3% | -$194K | ﹤0.01% | 1746 |
|
|
2021
Q2 | $7.06M | Buy |
39,950
+11,612
| +41% | +$2M | ﹤0.01% | 1803 |
|
|
2021
Q1 | $4.65M | Sell |
28,338
-13,697
| -33% | -$2.09M | ﹤0.01% | 2131 |
|
|
2020
Q4 | $5.85M | Buy |
42,035
+10,895
| +35% | +$1.37M | ﹤0.01% | 1969 |
|
|
2020
Q3 | $3.48M | Buy |
31,140
+3,748
| +14% | +$433K | ﹤0.01% | 2031 |
|
|
2020
Q2 | $2.55M | Buy |
27,392
+1,736
| +7% | +$148K | ﹤0.01% | 2188 |
|
|
2020
Q1 | $1.88M | Sell |
25,656
-2,853
| -10% | -$248K | ﹤0.01% | 2180 |
|
|
2019
Q4 | $2.4M | Buy |
28,509
+1,919
| +7% | +$149K | ﹤0.01% | 2455 |
|
|
2019
Q3 | $2.23M | Buy |
26,590
+3,538
| +15% | +$267K | ﹤0.01% | 2388 |
|
|
2019
Q2 | $1.51M | Sell |
23,052
-8,650
| -27% | -$498K | ﹤0.01% | 2647 |
|
|
2019
Q1 | $1.87M | Buy |
31,702
+6,920
| +28% | +$413K | ﹤0.01% | 2420 |
|
|
2018
Q4 | $1.31M | Sell |
24,782
-112,305
| -82% | -$6.17M | ﹤0.01% | 2570 |
|
|
2018
Q3 | $8.21M | Buy |
137,087
+124,181
| +962% | +$6.79M | 0.01% | 1375 |
|
|
2018
Q2 | $555K | Sell |
12,906
-2,767
| -18% | -$112K | ﹤0.01% | 3368 |
|
|
2018
Q1 | $546K | Buy |
15,673
+3,872
| +33% | +$141K | ﹤0.01% | 3317 |
|
|
2017
Q4 | $428K | Buy |
11,801
+5,006
| +74% | +$175K | ﹤0.01% | 3503 |
|
|
2017
Q3 | $217K | Buy |
+6,795
| New | +$208K | ﹤0.01% | 3895 |
|
|
2017
Q2 | – | Sell |
-7,725
| Closed | -$231K | – | 3911 |
|
|
2017
Q1 | $231K | Buy |
+7,725
| New | +$249K | ﹤0.01% | 3593 |
|
|
2016
Q4 | – | Sell |
-19,594
| Closed | -$586K | – | 4172 |
|
|
2016
Q3 | $586K | Buy |
+19,594
| New | +$572K | ﹤0.01% | 3339 |
|
Other funds holding MEDP
WA
RP
EIP
Credit Suisse's MEDP Position: Q1 2024 in Review
Credit Suisse reduced its Medpace (MEDP) stake by 0.98% in Q1 2024, selling an estimated $118K and leaving 34,062 shares worth $13.8M. The position accounts for 0.01% of the portfolio, ranked #781.
Credit Suisse first reported a position in MEDP in Q3 2016 and has held it in 29 quarters since. 597 funds tracked by Wall St. Rank hold MEDP as of Q1 2024.
- Credit Suisse held 34,062 shares of Medpace worth $13.8M as of Q1 2024.
- Credit Suisse sold 336 Medpace shares in Q1 2024, an estimated $118K.
- Medpace made up 0.01% of Credit Suisse's portfolio in Q1 2024, its #781 holding.
- Credit Suisse first reported a position in Medpace in Q3 2016 and has held it in 29 quarters since.
- 597 funds tracked by Wall St. Rank held Medpace as of Q1 2024.
Based on Credit Suisse's 13F filing for Q1 2024, filed 10 May 2024.